Back

Electro-acupuncture Alleviates METH Withdrawal-induced Spatial Memory Deficits by Restoring Astrocyte-drived Glutamate Uptake in dCA1

Shi, P.; Li, Z.; Xu, X.; Nie, J.; Liu, D.; Cai, Q.; Zhao, Y.; Guan, Y.; Ge, F.; Guan, X.

2020-05-26 neuroscience
10.1101/2020.05.20.106153 bioRxiv
Show abstract

Methamphetamine (METH) is frequently abused drug and produces cognitive deficits. METH could induce hyper-glutamatergic state in the brain, which could partially explain METH-related cognitive deficits, but the synaptic etiology remains incompletely understood. To address this issue, we explored the role of dCA1 tripartite synapses and the potential therapeutic effects of electro-acupuncture (EA) in the development of METH withdrawal-induced spatial memory deficits in mice. We found that METH withdrawal weakened astrocytic capacity of glutamate (Glu) uptake, but failed to change Glu release from dCA3, which lead to hyper-glutamatergic excitotoxicity at dCA1 tripartite synapses. By restoring the astrocytic capacity of Glu uptake, EA treatments suppressed the hyper-glutamatergic state and normalized the excitability of postsynaptic neuron in dCA1, finally alleviated spatial memory deficits in METH withdrawal mice. These findings indicate that astrocyte at tripartite synapses might be a key target for developing therapeutic interventions against METH-associated cognitive disorders, and EA represent a promising non-invasive therapeutic strategy for the management of drugs-caused neurotoxicity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Neuroscience Bulletin
11 papers in training set
Top 0.1%
17.8%
2
ACS Chemical Neuroscience
60 papers in training set
Top 0.1%
15.0%
3
eLife
5422 papers in training set
Top 8%
8.6%
4
Brain Research
35 papers in training set
Top 0.1%
4.9%
5
National Science Review
22 papers in training set
Top 0.3%
3.7%
6
Neurotherapeutics
11 papers in training set
Top 0.1%
2.1%
50% of probability mass above
7
Science Bulletin
22 papers in training set
Top 0.2%
2.1%
8
PLOS ONE
4510 papers in training set
Top 50%
1.9%
9
Life Sciences
25 papers in training set
Top 0.4%
1.9%
10
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.7%
11
Scientific Reports
3102 papers in training set
Top 57%
1.7%
12
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.7%
13
Neuropsychopharmacology
134 papers in training set
Top 2%
1.5%
14
European Journal of Pharmacology
11 papers in training set
Top 0.1%
1.4%
15
Translational Psychiatry
219 papers in training set
Top 3%
1.2%
16
Molecular Psychiatry
242 papers in training set
Top 3%
1.1%
17
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.0%
18
British Journal of Pharmacology
34 papers in training set
Top 0.4%
0.8%
19
Neuroscience Research
14 papers in training set
Top 0.1%
0.8%
20
Neuropharmacology
60 papers in training set
Top 0.6%
0.8%
21
Acta Biochimica et Biophysica Sinica
19 papers in training set
Top 0.7%
0.8%
22
Journal of Alzheimer’s Disease
39 papers in training set
Top 1%
0.8%
23
Neuroscience Letters
28 papers in training set
Top 1%
0.8%
24
Psychopharmacology
59 papers in training set
Top 0.6%
0.8%
25
Progress in Neurobiology
41 papers in training set
Top 2%
0.8%
26
eneuro
389 papers in training set
Top 9%
0.7%
27
npj Parkinson's Disease
89 papers in training set
Top 1%
0.7%
28
Clinical and Translational Medicine
30 papers in training set
Top 1%
0.7%
29
International Immunopharmacology
15 papers in training set
Top 0.6%
0.7%
30
Neuroscience
88 papers in training set
Top 3%
0.7%